Related Experiment Video
Updated: Oct 23, 2025

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Interstitial Lung Disease and Diffuse Alveolar Hemorrhage, the Two Key Pulmonary Manifestations in Microscopic
1Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National Boramae Medical Center, Seoul, Republic of Korea.
Abstract:
Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA)‒associated necrotizing vasculitis, which mainly affects small vessels in various organs, especially the lungs. The two key pulmonary manifestations, interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH), increase the morbidity and death rate of patients with MPA. ILD is more common in MPA than in other ANCA-associated vasculitis subsets and is primarily associated with myeloperoxidase-ANCA. Unlike alveolar hemorrhage due to pulmonary capillaritis, ILD can initially manifest as isolated pulmonary fibrosis. Of note, its most frequent radiographic pattern is the usual interstitial pneumonia pattern, similar to the characteristic pattern seen in idiopathic pulmonary fibrosis. In this review we present the pathogenesis, clinical manifestations, and radiographic and histopathologic features of ILD and DAH in MPA. We also briefly summarize the outcome and therapeutic options for the two conditions.
Insights
Microscopic polyangiitis (MPA) can cause lung issues like interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH). ILD in MPA often mimics idiopathic pulmonary fibrosis on imaging.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Immunology
Background:
- Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis affecting small vessels.
- Pulmonary manifestations, including interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH), significantly increase MPA morbidity and mortality.
- ILD is particularly prevalent in MPA, often linked to myeloperoxidase-ANCA and presenting as pulmonary fibrosis with a usual interstitial pneumonia pattern.
Purpose of the Study:
- To review the pathogenesis, clinical, radiographic, and histopathologic features of ILD and DAH in MPA.
- To summarize outcomes and therapeutic strategies for these pulmonary complications.
Main Methods:
- Literature review focusing on MPA, ILD, and DAH.
- Analysis of clinical, imaging, and histopathology data.
- Synthesis of current understanding of disease mechanisms and treatment.
Main Results:
- ILD in MPA is frequently associated with myeloperoxidase-ANCA.
- Radiographic findings of ILD in MPA often resemble idiopathic pulmonary fibrosis, specifically the usual interstitial pneumonia pattern.
- DAH and ILD represent critical pulmonary complications impacting MPA patient prognosis.
Conclusions:
- Understanding the distinct features of ILD and DAH in MPA is crucial for diagnosis and management.
- Early recognition and appropriate therapy for these pulmonary manifestations can improve patient outcomes.
- MPA-associated ILD shares radiographic similarities with idiopathic pulmonary fibrosis, necessitating careful differential diagnosis.
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Peripheral Artery Disease I: Introduction
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

